This is consistent with the observed MKP-2-deficient phenotype, as streptozotocin (STZ) injected SDF-1 transgenic mice exhibit improved glucose homeostasis and were protected from the development of diabetes through Akt activation in β-cells [41]. Here, CXCL12 is linked to diabetes mellitus.